FASN and nonpapillary renal cell carcinoma: Therefore, this study uncovers important regulatory mechanisms for the ERK pathway and lipid metabolism in ccRCC and provides an opportunity for the development of ccRCC treatment strategies targeting FASN or OGDHL m6A modification.